Latest Breaking News On - Kentaro tahara - Page 2 : comparemela.com
Japan, South Korea, and the African subcontinent are now covered by the Alliance. With the addition of two new WODA members – Nxera Pharma (formerly Sosei Heptares) and Veld Pharmaceuticals – WODA now provides access to over 200 million rare disease patients. TOKYO and ZUG, Switzerland, April 08, 2024 (GLOBE NEWSWIRE) The World Orphan Drug Alliance (WODA), a global alliance of commercial distributors dedicated to providing access to treatments for rare diseases and specialty medicines in comp
JapanTurkeyNew-zealandSouth-koreaSeoulSoult-ukpyolsiAustraliaTokyoLondonCity-ofUnited-kingdomIsraelTokyo, Japan and Cambridge, UK, 3 April 2024 - Nxera Pharma (“Nxera” or “the Company”; TSE: 4565) – formerly known as Sosei Group or Sosei Heptares – today announces the appointment of Japan pharmaceutical sector expert, Mr. Patrick Branch, as Head of Business Development for Japan and the APAC region. Mr. Branch will join Nxera’s global Business Development team that is led by Dr. Marcus Messenger. He will be based in Nxera’s Tokyo office and will oversee Japan and regional disease area strateg
JapanUnited-kingdomSeoulSoult-ukpyolsiSouth-koreaCambridgeCambridgeshireUnited-statesColumbia-universityNew-yorkLondonCity-of